Pe. Maligres et al., SYNTHESIS OF THE ORALLY-ACTIVE SPIROINDOLINE-BASED GROWTH-HORMONE SECRETAGOGUE, MK-677, Tetrahedron, 53(32), 1997, pp. 10983-10992
The preparation of the Merck Growth Hormone Secretagogue; MK-677 is de
scribed. A Fischer indole/reduction based strategy provides the novel
spiroindoline nucleus of this potent compound. This optimized sequence
necessitates the isolation of only one intermediate 10 and provides M
K-677 in 48% overall yield from isonipecotic acid 3. (C) 1997 Elsevier
Science Ltd.